Microorganism |
|
|
|
Antimicrobial |
![sort sort](../Images/sort_asc.gif) |
|
Reference |
Staphylococcus aureus (vancomycin-intermediate) |
0.25 |
0.5 |
≤0.25 - >4 |
Trimethoprim/Sulfamethoxazole![](/Images/relation.png) |
1130 |
Staphylococcus aureus (vancomycin-intermediate) |
1 |
1 |
0.5 - 2 |
Quinupristin/Dalfopristin (Synercid)![](/Images/relation.png) |
1130 |
Staphylococcus aureus (vancomycin-intermediate) |
2 |
2 |
0.5 - 2 |
Linezolid (PNU-100766, U-100766, Zyvox)![](/Images/relation.png) |
1130 |
Staphylococcus aureus (vancomycin-intermediate) |
>4 |
>4 |
≤0.12 - >4 |
Clindamycin (Cleocin)![](/Images/relation.png) |
1130 |
Staphylococcus aureus (vancomycin-intermediate) |
>4 |
>4 |
4 - >4 |
Levofloxacin (Levaquin, Quixin)![](/Images/relation.png) |
1130 |
Staphylococcus aureus (vancomycin-intermediate) |
>4 |
>4 |
>4 - ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin)![](/Images/relation.png) |
1130 |
Staphylococcus aureus (vancomycin-intermediate) |
>16 |
>16 |
0.06 - >16 |
Solithromycin (CEM-101 and OP-1068)![](/Images/relation.png) |
1130 |
Staphylococcus aureus (vancomycin-intermediate) |
>16 |
>16 |
0.25 - >16 |
Telithromycin (HMR 3647, RU-66647, Ketek)![](/Images/relation.png) |
1130 |
Staphylococcus aureus (vancomycin-intermediate) |
- |
1 |
? - ? |
Ceftaroline![](/Images/relation.png) |
1358 |
Staphylococcus aureus (vancomycin-intermediate) |
- |
2 |
? - ? |
Linezolid (PNU-100766, U-100766, Zyvox)![](/Images/relation.png) |
1358 |
Staphylococcus aureus (vancomycin-intermediate) |
- |
4 |
? - ? |
Daptomycin (Cubicin)![](/Images/relation.png) |
1358 |
Staphylococcus aureus (vancomycin-intermediate) |
- |
8 |
? - ? |
Vancomycin (Vancocyn, Lyphocin)![](/Images/relation.png) |
1358 |
Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
0.125 - 0.25 |
PD 0305970![](/Images/relation.png) |
225 |
Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
0.25 - 1 |
PD 0326448![](/Images/relation.png) |
225 |
Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
0.25 - ? |
Flavone + Vancomycin![](/Images/relation.png) |
1549 |
Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
0.25 - ? |
Naringenin + Vancomycin![](/Images/relation.png) |
1549 |
Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
0.25 - ? |
Naringin + Vancomycin![](/Images/relation.png) |
1549 |
Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
0.5 - ? |
Platencin![](/Images/relation.png) |
106 |
Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
0.5 - ? |
Platencin![](/Images/relation.png) |
517 |
Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
0.5 - ? |
Platensimycin![](/Images/relation.png) |
517 |
Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
0.5 - ? |
Platensimycin![](/Images/relation.png) |
106 |
Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
1 - 2 |
Linezolid (PNU-100766, U-100766, Zyvox)![](/Images/relation.png) |
726 |
Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
1 - 2 |
Tigecycline (GAR-936, Tigacyl)![](/Images/relation.png) |
476 |
Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
1 - 4 |
Garenoxacin (T-3811, BMS-284756)![](/Images/relation.png) |
225 |
Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
2 - ? |
Linezolid (PNU-100766, U-100766, Zyvox)![](/Images/relation.png) |
106 |
Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
2 - ? |
Linezolid (PNU-100766, U-100766, Zyvox)![](/Images/relation.png) |
517 |
Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
4 - 8 |
Vancomycin (Vancocyn, Lyphocin)![](/Images/relation.png) |
225 |
Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
8 - 16 |
Gatifloxacin (Tequin)![](/Images/relation.png) |
225 |